[EN] AKT ISOZYME-SPECIFIC COVALENT INHIBITORS DERIVED FROM REDOX-SIGNALING LIPIDS<br/>[FR] INHIBITEURS COVALENTS SPÉCIFIQUES DE L'ISOZYME AKT DÉRIVÉS DE LIPIDES DE SIGNALISATION REDOX
申请人:UNIV CORNELL
公开号:WO2018226794A1
公开(公告)日:2018-12-13
The present invention is directed to a compound of Formula (I) wherein A, X, Y, R1, R2, R3, R4, and n are as described herein. The present invention also relates to: 1) a method of treating cancer using a compound of Formula (I) and 2) a method of inhibiting pan-Akt in a cell or a tissue using a compound of Formula (I).
本发明涉及一种化合物(I)的公式,其中A,X,Y,R1,R2,R3,R4和n的描述如下。本发明还涉及:1)使用化合物(I)治疗癌症的方法和2)使用化合物(I)抑制细胞或组织中的泛Akt的方法。